Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Sodium Zirconium Cyclosilicate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,638Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AstraZeneca calls off two late-stage potassium drug trials
    AstraZeneca calls off two late-stage potassium drug trials

    02 Dec 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-scrap-two-trials-drug-that-curbs-potassium-2023-12-01/

    REUTERS
    02 Dec 2023
    Share Share
    LOKELMA Granted FTD by FDA in Chronic Hemodialysis With Hyperkalemia
    LOKELMA Granted FTD by FDA in Chronic Hemodialysis With Hyperkalemia

    17 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211117006015/en

    BUSINESSWIRE
    17 Nov 2021
    Share Share
    Lokelma label update approved in China for patients with hyperkalaemia
    Lokelma label update approved in China for patients with hyperkalaemia

    24 Nov 2020

    // PRESS RELEASE

    https://www.astrazeneca.com/media-centre/press-releases/2020/lokelma-label-update-approved-in-china-for-patients-with-hyperka.html

    PRESS RELEASE
    24 Nov 2020
    Share Share
    EU approves label update for AZ' Lokelma
    EU approves label update for AZ' Lokelma

    04 May 2020

    // Selina McKee PHARMATIMES

    http://www.pharmatimes.com/news/eu_approves_label_update_for_az_lokelma_1339580

    Selina McKee PHARMATIMES
    04 May 2020
    Share Share
    Lokelma US label updated to include dosing guidance for hyperkalaemia
    Lokelma US label updated to include dosing guidance for hyperkalaemia

    27 Apr 2020

    // ASTRAZENECA

    https://www.astrazeneca.com/media-centre/medical-releases/lokelma-us-label-updated-to-include-dosing-guidance-for-the-treatment-of-hyperkalaemia-in-patients-with-end-stage-renal-disease-on-haemodialysis.html

    ASTRAZENECA
    27 Apr 2020
    Share Share
    China approves AstraZeneca's Lokelma to treat hyperkalaemia
    China approves AstraZeneca's Lokelma to treat hyperkalaemia

    08 Jan 2020

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/34/15198/china-approves-astrazenecas-lokelma-to-treat-hyperkalaemia.html

    BIOSPECTRUM ASIA
    08 Jan 2020
    Share Share